Johnson & Johnson prepares to resume COVID vaccine trial in US

covid
Credit: Unsplash/CC0 Public Domain

Johnson & Johnson said Friday it was preparing to resume the clinical trial of its experimental vaccine to fight COVID-19, which was suspended last week after a volunteer fell ill.

J&J said it was "planning to resume " for the phase 3 trial, which began in late September and should ultimately include 60,000 participants.

"After a thorough evaluation of a serious medical event experienced by one study participant, no clear cause has been identified," the group said in a statement.

"The company has found no evidence that the vaccine candidate caused the event."


Explore further

Follow the latest news on the coronavirus (COVID-19) outbreak

© 2020 AFP

Citation: Johnson & Johnson prepares to resume COVID vaccine trial in US (2020, October 23) retrieved 23 January 2021 from https://medicalxpress.com/news/2020-10-johnson-resume-covid-vaccine-trial.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
8 shares

Feedback to editors

User comments